Clin2
NCT07605728Likely a fitRecruiting

Probiotics to ease stomach problems from breast cancer treatment

Breast CancerChemotherapy-induced Diarrhea

Part of Cancer, Skin clinical trials.

This trial tests whether a special probiotic supplement (good bacteria) can reduce belly discomfort caused by abemaciclib, a hormone therapy drug for early breast cancer. You would take the supplement alongside your cancer treatment to see if it helps with stomach side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have early-stage hormone receptor-positive breast cancer and are about to start abemaciclib treatment with hormone therapy
  • You finished chemotherapy at least 3 weeks ago, with side effects mostly resolved
  • You have adequate blood counts and liver function (checked by blood tests)
  • You are willing to avoid all other probiotic or prebiotic supplements during the trial
  • You can attend study visits and follow the treatment plan
  • You are not pregnant, breastfeeding, or currently on antibiotics for an infection

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06039644Recruiting
Probiotics for breast cancer patients on chemotherapy

This trial tests whether taking a probiotic supplement can help breast cancer patients going through chemotherapy. If you are between 20 and 80 years old, have stage I-III breast cancer, and are receiving certain chemo drugs, this study may be for you.

Taipei
NCT07553234Not yet recruiting
Gut Health and Side Effects from Breast Cancer Hormone Treatment

This study looks at how the bacteria in your digestive system may affect side effects from abemaciclib, a hormone-based breast cancer drug. By collecting stool samples, researchers hope to understand which patients might experience fewer problems and how to better manage treatment.

Chicago, Illinois
NCT04362826Recruiting
Trial tests a probiotic to change gut microbes in breast cancer

This study gives a probiotic to see whether it safely changes the gut’s bacteria and fungi (your “microbiome”) in people with breast cancer. The researchers want to learn if this shift in gut microbes might support breast cancer treatment or health during care.

Cleveland, Ohio
NCT07465497Enrolling by invitation
Preventing Chemo Brain with Prebiotics and Synbiotics

This trial tests whether taking a special blend of prebiotics and synbiotics (friendly bacteria and food for them) can help prevent or reduce memory and thinking problems that sometimes happen during chemotherapy for breast cancer.

Zapopan, Jalisco
NCT07406594Not yet recruiting
Gut microbiome changes during abemaciclib in breast cancer

This study looks at how abemaciclib (Verzenio) affects the bacteria in your gut (the microbiome). If you have a certain type of breast cancer and are starting this treatment, researchers want to understand why it works the way it does.

Burlington, Vermont
NCT06768931Recruiting· Phase 2
Combination therapy before surgery for triple-negative breast cancer

This trial tests adding an immunotherapy drug to standard chemotherapy before surgery for triple-negative breast cancer. The goal is to see if this combination works better than chemotherapy alone.

Lanzhou, Gansu

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.